Rates of cutaneous metastases from different internal malignancies: Experience from a Taiwanese medical center

Journal of the American Academy of Dermatology

Volumn 60, Issue 3, 2009, Pages 379-387

  Hu, Stephen Chu Sung ^a   Chen, Gwo Shing ^a,b   Wu, Ching Shuang ^c   Chai, Chee Yin ^a   Chen, Wan Tzu ^a   Lan, Cheng Che E ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CXCR4;

ADENOCARCINOMA; ARTICLE; BREAST CARCINOMA; CAUCASIAN; COLON CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; MOUTH CARCINOMA; POPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SKIN METASTASIS; STOMACH CARCINOMA; TAIWAN; TUMOR CELL; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADENOCARCINOMA; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LUNG NEOPLASMS; MOUTH NEOPLASMS; RECEPTORS, CCR10; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 60149092889     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.10.007     Document Type: Article

References (63)

1. Abrams H.L., Spiro R., and Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3 (1950) 74-85
2. Reingold I.M. Cutaneous metastases from internal carcinoma. Cancer 19 (1966) 162-168
3. Rosen T. Cutaneous metastases. Med Clin North Am 64 (1980) 885-900
4. Spencer P.S., and Helm T.N. Skin metastases in cancer patients. Cutis 39 (1987) 119-121
5. Lookingbill D.P., Spangler N., and Sexton F.M. Skin involvement as the presenting sign of internal carcinoma: a retrospective study of 7316 cancer patients. J Am Acad Dermatol 22 (1990) 19-26
6. Lookingbill D.P., Spangler N., and Helm K.F. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 29 (1993) 228-236
7. Schwartz R.A. Cutaneous metastatic disease. J Am Acad Dermatol 33 (1995) 161-182
8. Krathen R.A., Orengo I.F., and Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J 96 (2003) 164-167
9. Mueller T.J., Wu H., Greenberg R.E., Hudes G., Topham N., Lessin S.R., et al. Cutaneous metastases from genitourinary malignancies. Urology 63 (2004) 1021-1026
10. Suzuki N. Multiple skin metastases from cancer of internal organs. J Cancer Res 3 (1918) 357-388
11. White Jr. J.W. Evaluating cancer metastatic to the skin. Geriatrics 40 (1985) 67-73
12. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
13. Murakami T., Cardones A.R., and Hwang S.T. Chemokine receptors and melanoma metastasis. J Dermatol Sci 36 (2004) 71-78
14. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198 (2003) 1337-1347
15. Simonetti O., Goteri G., Lucarini G., Filosa A., Pieramici T., Rubini C., et al. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur J Cancer 42 (2006) 1181-1187
16. Morales J., Homey B., Vicari A.P., Hudak S., Oldham E., Hedrick J., et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A 96 (1999) 14470-14475
17. Homey B., Wang W., Soto H., Buchanan M.E., Wiesenborn A., Catron D., et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164 (2000) 3465-3470
18. Chen G.S., Yu H.S., Lan C.C., Chow K.C., Lin T.Y., Kok L.F., et al. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol 154 (2006) 910-918
19. Chu C.Y., Cha S.T., Chang C.C., Hsiao C.H., Tan C.T., Lu Y.C., et al. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha-directed invasion of human basal cell carcinoma cells. Oncogene 26 (2007) 2491-2501
20. Narducci M.G., Scala E., Bresin A., Caprini E., Picchio M.C., Remotti D., et al. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 107 (2006) 1108-1115
21. Fedyk E.R., Jones D., Critchley H.O., Phipps R.P., Blieden T.M., and Springer T.A. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 166 (2001) 5749-5754
22. Toksoy A., Müller V., Gillitzer R., and Goebeler M. Biphasic expression of stromal cell-derived factor-1 during human wound healing. Br J Dermatol 157 (2007) 1148-1154
23. Hu S.C., Chen G.S., Lu Y.W., Wu C.S., and Lan C.C. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal. J Eur Acad Dermatol Venereol 22 (2008) 735-740
24. Department of Health. Annual report of cancer registry, 2005. [in Chinese] (2005), Department of Health, Executive Yuan, Taipei
25. Li C.I., Malone K.E., and Daling J.R. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163 (2003) 49-56
26. Braun K.L., Fong M., Gotay C.C., and Chong C.D. Ethnic differences in breast cancer in Hawaii: age, stage, hormone receptor status, and survival. Pac Health Dialog 11 (2004) 146-153
27. Braun K.L., Fong M., Gotay C., Pagano I.S., and Chong C. Ethnicity and breast cancer in Hawaii: increased survival but continued disparity. Ethn Dis 15 (2005) 453-460
28. Blackman D.J., and Masi C.M. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes?. J Clin Oncol 24 (2006) 2170-2178
29. Friedell G.H., Soto E.A., Kumaoka S., Hirota T., Hayward J.L., and Bulbrook R.D. Pathology of primary tumors and axillary lymph nodes in British and Japanese women with breast cancer. Breast Cancer Res Treat 3 (1983) 165-169
30. Klonoff-Cohen H.S., Schaffroth L.B., Edelstein S.L., Molgaard C., and Saltzstein S.L. Breast cancer histology in Caucasians, African Americans, Hispanics, Asians, and Pacific Islanders. Ethn Health 3 (1998) 189-198
31. Li C.I., Malone K.E., and Daling J.R. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11 (2002) 601-607
32. Pegoraro R.J., Karnan V., Nirmul D., and Joubert S.M. Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 46 (1986) 2117-2120
33. Nomura Y., Kobayashi S., Takatani O., Sugano H., Matsumoto K., and McGuire W.L. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res 37 (1977) 106-110
34. Huang C.S., Chen Y.C., Wang M., Lin J.K., and Chang K.J. HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors. J Formos Med Assoc 94 (1995) 660-665
35. Choi D.H., Shin D.B., Lee M.H., Lee D.W., Dhandapani D., Carter D., et al. A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer 98 (2003) 1587-1595
36. Porter P.L., Lund M.J., Lin M.G., Yuan X., Liff J.M., Flagg E.W., et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer 100 (2004) 2533-2542
37. Tang N.L., Pang C.P., Yeo W., Choy K.W., Lam P.K., Suen M., et al. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst 91 (1999) 882-885
38. Fung L.F., Wong N., Tang N., Lau A., Wong V., Pang C.P., et al. Genetic imbalances in pT2 breast cancers of southern Chinese women. Cancer Genet Cytogenet 124 (2001) 56-61
39. Tang N.L., Choy K.W., Pang C.P., Yeo W., and Johnson P.J. Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing. Clin Chim Acta 313 (2001) 179-185
40. Suter N.M., Ray R.M., Hu Y.W., Lin M.G., Porter P., Gao D.L., et al. BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 13 (2004) 181-189
41. Ries L.A.G., Eisner M.P., and Kosary C.L. SEER cancer statistics review, 1975-2001. Bethesda (MD): National Cancer Institute. Available from: URL:. http://www.seer.cancer.gov Accessed September 15, 2008
42. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide: International Agency for Research on Cancer (IARC), cancer base No. 5, version 2.0 (2004), IARC Press, Lyon
43. Yu H., Jin F., Shu X.O., Li B.D., Dai Q., Cheng J.R., et al. Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11 (2002) 705-712
44. Ursin G., Wilson M., Henderson B.E., Kolonel L.N., Monroe K., Lee H.P., et al. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?. Cancer Res 61 (2001) 3326-3329
45. Carey L.A., Perou C.M., Livasy C.A., Dressler L.G., Cowan D., Conway K., et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295 (2006) 2492-2502
46. Kurebayashi J., Moriya T., Ishida T., Hirakawa H., Kurosumi M., Akiyama F., et al. The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast 16 Suppl (2007) S72-S77
47. Scully C., and Bedi R. Ethnicity and oral cancer. Lancet Oncol 1 (2000) 37-42
48. Chen P.H., Shieh T.Y., Ho P.S., Tsai C.C., Yang Y.H., Lin Y.C., et al. Prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan. BMC Cancer 7 (2007) 101
49. Paterson I.C., Eveson J.W., and Prime S.S. Molecular changes in oral cancer may reflect etiology and ethnic origin. Eur J Cancer B Oral Oncol 32B (1996) 150-153
50. Zain R.B. Cultural and dietary risk factors of oral cancer and precancer-a brief overview. Oral Oncol 37 (2001) 205-210
51. Ho C., Murray N., Laskin J., Melosky B., Anderson H., and Bebb G. Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America. Lung Cancer 49 (2005) 225-231
52. Yang C.H. EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. Lung Cancer 60 Suppl (2008) S23-S30
53. Chang A., Parikh P., Thongprasert S., Tan E.H., Perng R.P., Ganzon D., et al. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study. J Thorac Oncol 1 (2006) 847-855
54. Thomas S.K., Fossella F.V., Liu D., Schaerer R., Tsao A.S., Kies M.S., et al. Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program. Clin Lung Cancer 7 (2006) 326-331
55. Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.M., Hertz-Picciotto I., Duggan H.M., et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 97 (1992) 259-267
56. Tapio S., and Grosche B. Arsenic in the etiology of cancer. Mutat Res 612 (2006) 215-246
57. Cantor K.P., and Lubin J.H. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol Appl Pharmacol 222 (2007) 252-257
58. Celik I., Gallicchio L., Boyd K., Lam T.K., Matanoski G., Tao X., et al. Arsenic in drinking water and lung cancer: a systematic review. Environ Res 108 (2008) 48-55
59. Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. Harrison's principles of internal medicine. 16th ed (2005), McGraw-Hill Medical Publishing Division, New York
60. Dreizen S., Dhingra H.M., Chiuten D.F., Umsawasdi T., and Valdivieso M. Cutaneous and subcutaneous metastases of lung cancer: clinical characteristics. Postgrad Med 80 (1986) 111-116
61. Brodland D.G., and Zitelli J.A. Mechanisms of metastasis. J Am Acad Dermatol 27 (1992) 1-8
62. Chambers A.F., Naumov G.N., Vantyghem S.A., and Tuck A.B. Molecular biology of breast cancer metastasis: clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res 2 (2000) 400-407
63. Larsen W.J. Human embryology (1993), Churchill Livingstone, New York